Case concerns allegations that ex-senior vice president of business development at Skye Orthobiologics misappropriated ...

Biotech walks away with another win as Fed Circ upholds PTAB decision | Labcorp’s attempt to overturn $373m verdict fails | ...

Two large teams leave Locke Lord following Troutman Pepper merger | Buchanan opens Chicago office with a large life sciences ...

12 December 2024 Firm expands its Mechanical & Electromechanical Technologies Practice with latest addition | Partner brings ...

The Japanese pharma company files complaint against Lupin Pharmaceuticals | Suit alleges patent infringement over the company ...

Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim ...

Massachusetts medical research company is awarded damages following a jury verdict that found a Japanese pharma had infringed on its patent | Patent relates to Duchenne muscular dystrophy treatment.

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

The act’s one-sided provisions and its disproportionate remedies cannot pass constitutional muster, argues John Cox of Barnes & Thornburg.

Pair of generic drug makers challenged validity of patent on priority, novelty and inventive step | EPO found the patent did not introduce any new matter not originally disclosed in the pharma company ...